Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
133.9 USD | -0.78% |
|
-4.07% | +1.87% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.87% | 13.58B | |
+18.94% | 125B | |
+13.86% | 108B | |
-7.37% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-14.04% | 16.37B | |
+27.77% | 11.66B | |
+94.13% | 9.17B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Oppenheimer Adjusts Neurocrine Biosciences Price Target to $216 From $200, Maintains Outperform Rating